Anika Therapeutics (ANIK) Other Working Capital Changes (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Other Working Capital Changes data on file, last reported at $1.7 million in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $1.7 million, up 751.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$802000.0 (up 11.18% YoY), and the FY2025 annual result was -$2.3 million, down 317.03% from the prior year.
• Other Working Capital Changes grew to $1.7 million in Q1 2026 per ANIK's latest filing, from -$1.3 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $1.8 million in Q4 2022 and troughed at -$2.0 million in Q2 2022.
• A 5-year average of -$54411.8 and a median of -$54000.0 in 2024 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2025: Other Working Capital Changes surged 44481.93% in 2022, then plunged 2327.78% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $1.8 million in 2022, then tumbled by 86.02% to $258000.0 in 2023, then sank by 120.93% to -$54000.0 in 2024, then sank by 2327.78% to -$1.3 million in 2025, then soared by 231.81% to $1.7 million in 2026.
• Business Quant data shows ANIK's Other Working Capital Changes at $1.7 million in Q1 2026, -$1.3 million in Q4 2025, and -$219000.0 in Q3 2025.